High Intensity Intervallic Training in Children With Bronchiolitis Obliterans
PIBOHIIT
Effectiveness of a High-intensity Intervallic Training Program in Children and Adolescents With Post-infectious Bronchiolitis Obliterans: a Randomized Controlled Trial
1 other identifier
interventional
51
1 country
3
Brief Summary
Post-Infectious Bronchiolitis Obliterans (PIBO) is an irreversible obstructive lung disease characterized by subepithelial inflammation and fibrotic narrowing of the bronchioles after lower respiratory tract infection. This disease is diagnosed mainly in children, more frequently before the age of 2 years. Due to symptoms such as dry cough and dyspnea sensation, most of these patients have low levels of physical activity compared to healthy individuals. Physical activity can positively influence oxygen consumption, muscle strength, and quality of life. High levels of oxygen consumption are associated with a lower risk of respiratory disease and hospitalization. High-intensity interval training (HIIT) may be an effective way to improve oxygen consumption, muscle strength, and quality of life in patients with chronic diseases. HIIT has been shown to produce less dyspnea sensation and to be more entertaining in children and adolescents with respiratory disease compared to continuous training. Thus, the investigators propose to perform telematically real-time guided training to reduce travel times and additional costs to patients. Objective: To analyze the effects of a telematically supervised high-intensity intervallic training program on aerobic fitness, as well as functional/clinical outcomes in patients with PIBO. Methods: Randomized controlled trial with two groups. Exercise group: 16-week HIIT training conducted telematically; Control group: will follow the routine physician's recommendations. Patients will be recruited at Vall D'Hebrón University Hospital (Barcelona), Niño Jesús University Hospital (Madrid), and Donostia Universitary Hospital (San Sebastián). Criteria for participation: (I) Diagnosis of PIBO; (II) Clinically stable at the time of the assessments; (III) Age between 6 to 20 years old.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2023
CompletedStudy Start
First participant enrolled
May 29, 2023
CompletedFirst Posted
Study publicly available on registry
May 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2024
CompletedDecember 6, 2024
December 1, 2024
1.2 years
April 24, 2023
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in peak oxygen consumption
Change in peak oxygen consumption (mL/kg/min) will be evaluated through cardiopulmonary exercise testing (CPET).
Change from baseline to 16 weeks
Change in time to ventilatory threshold
Change in time to ventilatory threshold (minutes) will be evaluated through cardiopulmonary exercise testing (CPET).
Change from baseline to 16 weeks
Change in percent oxygen consumption at ventilatory threshold
Change in percent oxygen consumption at ventilatory threshold will be evaluated through cardiopulmonary exercise testing (CPET).
Change from baseline to 16 weeks
Change in ventilatory efficiency
Change in ventilatory efficiency will be evaluated by combining ventilation (VE) and carbon dioxide production (VCO2) measurements to report VE/VCO2 ratio, evaluated through cardiopulmonary exercise testing (CPET).
Change from baseline to 16 weeks
Secondary Outcomes (11)
Change in forced expiratory volume in the first second
Change from baseline to 16 weeks
Change in forced vital capacity
Change from baseline to 16 weeks
Change in forced expiratory flow between 25 and 75% of forced vital capacity
Change from baseline to 16 weeks
Change in muscle strength
Change from baseline to 16 weeks
Change in lower body strength
Change from baseline to 16 weeks
- +6 more secondary outcomes
Other Outcomes (3)
Height in meters
Change from baseline to 16 weeks
Weight in kilograms
Change from baseline to 16 weeks
Daily physical activity level
Change from baseline to 16 weeks
Study Arms (2)
Exercise group
EXPERIMENTAL16 weeks of a "High Intensity Interval Training" exercise program conducted telematically with real time supervision twice a week. The exercise program consists of a circuit of exercises aiming to achieve a target heart rate for each fitness level.
Control group
NO INTERVENTIONRoutine physician recommendations for physical activity.
Interventions
Participants will perform a 16-week High Intensity Interval Training exercise program, twice a week. The intervention will be conducted telematically with real time supervision.
Eligibility Criteria
You may qualify if:
- Diagnosis of Postinfectious bronchiolitis obliterans;
- Clinical stability at the time of the assessments;
- Age between 6 and 20 years old.
You may not qualify if:
- Symptoms of pulmonary exacerbation during the last four weeks;
- Diagnosis of other cardiorespiratory diseases leading to symptoms of persistent respiratory dysfunction;
- Difficulty in comprehension or musculoskeletal alterations that may influence the assessments;
- Pregnancy;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hospital Universitario Donostia
Donostia / San Sebastian, Basque Country, 20014, Spain
Hospital Universitari Vall d'Hebron
Barcelona, Catalonia, 08035, Spain
Hospital Universitario Infantil Niño Jesús
Madrid, 28009, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Márcio VF Donadio, PhD
Universitat Internacional de Catalunya
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The evaluators and care providers will be masked to the allocation of the patients. Given the nature of the intervention, it is not possible to mask patients or monitors in charge of supervising the execution of the exercise training.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 24, 2023
First Posted
May 31, 2023
Study Start
May 29, 2023
Primary Completion
July 29, 2024
Study Completion
July 29, 2024
Last Updated
December 6, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- After completion of study, the data will be stored for as long as necessary to meet any possible responsibilities derived from the study.
- Access Criteria
- Access will be given only to the researchers of the study.
The investigators will collect patients' personal data and clinical history by means of the information delivered by the participating hospital. These data will be stored and coded in an Excel file in order to protect confidentiality before, during and after the study. All information will be entered and stored electronically in the institutional platform REDCAP hosted on the hospitals' server.